XBiotech (XBIT) Competitors $2.54 -0.06 (-2.31%) Closing price 04:00 PM EasternExtended Trading$2.53 -0.01 (-0.39%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock XBIT vs. TKNO, CAPR, REPL, CGC, ALEC, MREO, UPXI, CADL, ALDX, and SCPHShould you be buying XBiotech stock or one of its competitors? The main competitors of XBiotech include Alpha Teknova (TKNO), Capricor Therapeutics (CAPR), Replimune Group (REPL), Canopy Growth (CGC), Alector (ALEC), Mereo BioPharma Group (MREO), Upexi (UPXI), Candel Therapeutics (CADL), Aldeyra Therapeutics (ALDX), and scPharmaceuticals (SCPH). These companies are all part of the "pharmaceutical products" industry. XBiotech vs. Its Competitors Alpha Teknova Capricor Therapeutics Replimune Group Canopy Growth Alector Mereo BioPharma Group Upexi Candel Therapeutics Aldeyra Therapeutics scPharmaceuticals XBiotech (NASDAQ:XBIT) and Alpha Teknova (NASDAQ:TKNO) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, media sentiment, analyst recommendations, dividends, earnings, institutional ownership and profitability. Is XBIT or TKNO more profitable? XBiotech has a net margin of 0.00% compared to Alpha Teknova's net margin of -55.24%. XBiotech's return on equity of -15.60% beat Alpha Teknova's return on equity.Company Net Margins Return on Equity Return on Assets XBiotechN/A -15.60% -14.64% Alpha Teknova -55.24%-26.51%-18.40% Do analysts prefer XBIT or TKNO? Alpha Teknova has a consensus price target of $10.00, indicating a potential upside of 101.61%. Given Alpha Teknova's stronger consensus rating and higher probable upside, analysts clearly believe Alpha Teknova is more favorable than XBiotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score XBiotech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Alpha Teknova 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.67 Do insiders & institutionals hold more shares of XBIT or TKNO? 55.7% of XBiotech shares are held by institutional investors. Comparatively, 13.8% of Alpha Teknova shares are held by institutional investors. 30.8% of XBiotech shares are held by company insiders. Comparatively, 12.5% of Alpha Teknova shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has more volatility and risk, XBIT or TKNO? XBiotech has a beta of 0.85, suggesting that its share price is 15% less volatile than the S&P 500. Comparatively, Alpha Teknova has a beta of 0.41, suggesting that its share price is 59% less volatile than the S&P 500. Which has stronger valuation & earnings, XBIT or TKNO? Alpha Teknova has higher revenue and earnings than XBiotech. Alpha Teknova is trading at a lower price-to-earnings ratio than XBiotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioXBiotechN/AN/A-$38.53M-$0.92-2.76Alpha Teknova$37.74M7.03-$26.75M-$0.42-11.81 Does the media refer more to XBIT or TKNO? In the previous week, XBiotech had 1 more articles in the media than Alpha Teknova. MarketBeat recorded 4 mentions for XBiotech and 3 mentions for Alpha Teknova. Alpha Teknova's average media sentiment score of 0.83 beat XBiotech's score of 0.81 indicating that Alpha Teknova is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment XBiotech 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Alpha Teknova 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryXBiotech and Alpha Teknova tied by winning 8 of the 16 factors compared between the two stocks. Get XBiotech News Delivered to You Automatically Sign up to receive the latest news and ratings for XBIT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding XBIT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XBIT vs. The Competition Export to ExcelMetricXBiotechMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$77.44M$3.32B$6.01B$10.23BDividend YieldN/A2.29%5.66%4.69%P/E Ratio-2.7622.1185.3526.57Price / SalesN/A416.63582.95179.01Price / CashN/A47.1938.3262.20Price / Book0.4210.2112.726.53Net Income-$38.53M-$52.40M$3.30B$275.87M7 Day Performance-3.79%0.90%1.07%-1.40%1 Month Performance-9.29%12.36%7.61%5.16%1 Year Performance-63.56%30.17%79.71%31.51% XBiotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XBITXBiotech1.1104 of 5 stars$2.54-2.3%N/A-63.3%$77.44MN/A-2.76100News CoveragePositive NewsAnalyst ForecastTKNOAlpha Teknova2.0878 of 5 stars$5.65-6.9%$10.00+77.0%-0.2%$324.84M$37.74M-13.45240Positive NewsAnalyst ForecastCAPRCapricor Therapeutics2.2727 of 5 stars$7.41+4.5%$22.25+200.3%-56.0%$324.13M$22.27M-4.52101Analyst ForecastREPLReplimune Group4.7003 of 5 stars$4.34+5.1%$6.50+49.8%-60.7%$322.37MN/A-1.34210Positive NewsCGCCanopy Growth0.9227 of 5 stars$1.57+17.2%N/A-59.1%$321.40M$225.65M-0.523,150Analyst ForecastOptions VolumeGap DownHigh Trading VolumeALECAlector3.6006 of 5 stars$3.05-1.6%$4.17+36.6%-36.4%$313.76M$100.56M-2.63270Analyst ForecastMREOMereo BioPharma Group2.2853 of 5 stars$1.96+1.0%$7.40+277.6%-49.3%$308.46M$10M-28.0040News CoveragePositive NewsAnalyst ForecastUPXIUpexi2.6621 of 5 stars$5.62+7.7%$15.50+175.8%+184.2%$307.11M$15.81M0.00130Positive NewsCADLCandel Therapeutics2.4691 of 5 stars$5.40-2.5%$20.00+270.4%+9.3%$304.12MN/A-7.8360Analyst ForecastALDXAldeyra Therapeutics1.9673 of 5 stars$5.21+2.8%$9.50+82.3%+8.6%$303.67MN/A-6.1310Positive NewsAnalyst ForecastSCPHscPharmaceuticals4.0014 of 5 stars$5.67+0.4%$7.78+37.3%N/A$301.14M$36.33M-3.1330Positive NewsAnalyst Forecast Related Companies and Tools Related Companies TKNO Competitors CAPR Competitors REPL Competitors CGC Competitors ALEC Competitors MREO Competitors UPXI Competitors CADL Competitors ALDX Competitors SCPH Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XBIT) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenIf you're a futures trader (or want to be one), this could be the biggest shift you'll ever see in the prop fi...Neuro Street Trading Academy | SponsoredThe best AI stock you aren’t watching (but Elon is)Elon Musk's AI empire is already being built... not in the spotlight, but in the background. One public cou...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingThe warning signs that preceded the 2008 crash are reappearing: an irrational NASDAQ bubble, a record-high gol...StockEarnings | SponsoredU.S. Government Sparking Crypto RallyAltcoin ETFs could surge prices (do this now) My "Crypto Bull Run Millionaire Blueprint" breaks down exactl...Crypto 101 Media | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMiss This IRS Strategy Now, Regret It LaterWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XBiotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share XBiotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
